Latest News and Press Releases
Want to stay updated on the latest news?
-
- $1.5 Million Purchase Price for Wrist Splint Product Assets - Current Annualized Sales Approaching...
-
MINNEAPOLIS, May 21, 2012 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that the Company is scheduled to participate in the Jefferies 2012 Global Healthcare Conference...
-
MINNEAPOLIS, May 10, 2012 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that the Company is scheduled to participate in the 2012 InvestMNt Conference being held at the...
-
MINNEAPOLIS, May 1, 2012 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that the Company is scheduled to participate in the Bank of America Merrill Lynch 2012 Health Care...
-
Net revenue increases 12% to $23.8 million, exceeding the top end of guidance EPS increases 20% to $0.12, also exceeding the top end of guidance Raising 2012 revenue guidance to a range...
-
Net revenue increases 6% to $22.1 million EPS increases 8% to $0.13 Maintaining 2012 guidance for 9% revenue growth and 15% EPS growth, excluding one-time items in 2011 Finishes year...
-
MINNEAPOLIS, Feb. 1, 2012 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that it is marketing a reprocessing service for the ClosureFAST radiofrequency ablation catheter in...
-
MINNEAPOLIS, Nov. 29, 2011 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that the Company is scheduled to present at the 6th Annual Canaccord Genuity Cardiovascular,...
-
MINNEAPOLIS, Nov. 22, 2011 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that the Company is scheduled to present at the 23rd Annual Piper Jaffray Health Care Conference...
-
Net revenue increases 22% to record $24.3 million EPS increases 144% to $0.22 Revising full-year 2011 guidance to revenues between $90.2-$90.6 million, EPS $0.56-$0.58 Establishing...